https://www.selleckchem.com/products/a-769662.html
1 (range 0-61) ETDRS letters and in group B was 14.3 (range 0-35) ETDRS letters. Mean CDVA improved to 65.7 (range 0-85) and 50.8 (range 20-76) ETDRS letters in group A and B, respectively. Anti-VEGF monotherapy eyes improved from 35 and 46 ETDRS letters to 70 and 85 ETDRS letters, respectively. Additional anti-VEGF therapy has no added advantage in speed of resolution of macular edema due to ER. A randomized controlled trial with steroids sparing "anti-VEGF monotherapy" may verify our observations. Additional anti-VEGF therapy has no
Respect!
Kommentar
Delen
